Literature DB >> 20201672

Galactomannan detection and diagnosis of invasive aspergillosis.

J Peter Donnelly, Mariske M Leeflang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20201672     DOI： 10.1086/651161

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

1.  Serum galactomannan surveillance may be safely withdrawn from antifungal management of hematology patients on effective antimold prophylaxis: a pilot single-center study.

Authors:  R F Duarte; I Sánchez-Ortega; M Arnan; B Patiño; J Ayats; A Sureda; M Cuenca-Estrella
Journal:  Bone Marrow Transplant       Date:  2016-10-31       Impact factor: 5.483

2.  Galactomannan testing during mold-active prophylaxis.

Authors:  Oliver A Cornely
Journal:  Clin Infect Dis       Date:  2014-08-27       Impact factor: 9.079

3.  The limited role of serum galactomannan assay in screening for invasive pulmonary aspergillosis in allogeneic stem cell transplantation recipients on micafungin prophylaxis: a retrospective study.

Authors:  Ryul Kim; Youngil Koh; Dong-Yeop Shin; Pyoeng Gyun Choe; Nam Joong Kim; Sung-Soo Yoon; Myoung-Don Oh; Wan Beom Park; Inho Kim
Journal:  Blood Res       Date:  2017-12-26

Review 4.  Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper.

Authors:  Ibai Los-Arcos; Gloria Iacoboni; Manuela Aguilar-Guisado; Laia Alsina-Manrique; Cristina Díaz de Heredia; Claudia Fortuny-Guasch; Irene García-Cadenas; Carolina García-Vidal; Marta González-Vicent; Rafael Hernani; Mi Kwon; Marina Machado; Xavier Martínez-Gómez; Valentín Ortiz Maldonado; Carolina Pinto Pla; José Luis Piñana; Virginia Pomar; Juan Luis Reguera-Ortega; Miguel Salavert; Pere Soler-Palacín; Lourdes Vázquez-López; Pere Barba; Isabel Ruiz-Camps
Journal:  Infection       Date:  2020-09-26       Impact factor: 7.455

5.  Diagnostic-driven antifungal therapy in neutropenic patients using the D-index and serial serum galactomannan testing.

Authors:  Marcia Garnica; Aline Sinhorelo; Laura Madeira; Rodrigo Portugal; Marcio Nucci
Journal:  Braz J Infect Dis       Date:  2016-06-06       Impact factor: 3.257
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.